| Bioactivity | NCGC00351170 is an antiplatelet agent that disrupts the calcium- and integrin-binding protein 1 (CIB1)-αIIbβ3 interaction. NCGC00351170 inhibits thrombin-induced human platelet aggregation[1]. |
| CAS | 886536-76-1 |
| Formula | C18H14N2O6 |
| Molar Mass | 354.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Golla K, et al. Small-Molecule Disruptors of the Interaction between Calcium-and Integrin-Binding Protein 1 and Integrin αIIbβ3 as Novel Antiplatelet Agents[J]. ACS Pharmacology & Translational Science, 2024. |
NCGC00351170
CAS: 886536-76-1 F: C18H14N2O6 W: 354.31
NCGC00351170 is an antiplatelet agent that disrupts the calcium- and integrin-binding protein 1 (CIB1)-αIIbβ3 interact
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.